Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Hackel v. AVEO Pharmaceuticals, Inc. et al
Case Number:
1:19-cv-10783
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
July 27, 2020
Aveo Pharma Escapes Investors' Cancer Drug Stock-Drop Suit
A Massachusetts federal judge has tossed a securities class action alleging biopharmaceutical company Aveo and its executives misled investors about possible federal approval of a cancer drug, saying the company "explicitly warned the public" about the uncertainty of a clinical trial.
-
December 05, 2019
Investors Say Aveo Pharma Can't Shake Stock-Drop Suit
Investors who allege they were misled by Aveo Pharmaceuticals Inc. as to the effectiveness of its flagship children's cancer drug told a Massachusetts federal judge Wednesday that they have done enough to defeat Aveo's bid to get the suit tossed.
-
May 06, 2019
Pomerantz Nabs Lead In Aveo Pharma Stock-Drop Suit
Pomerantz LLP was named lead counsel and Andrews DeValerio LLP liaison counsel Monday in a proposed class action accusing Aveo Pharmaceuticals Inc. and its officers of misleading investors about the effectiveness of a candidate cancer drug just before a stock price plunge.
-
April 22, 2019
Aveo Pharma Stock-Drop Suit Lands In Massachusetts
A proposed class action accusing embattled Aveo Pharmaceuticals Inc., its CEO and two others of misleading investors ahead of a sharp January stock drop was moved to Massachusetts federal court Monday after the company's unopposed bid to transfer the suit from New York.